Glowing Bone Mineral Nanofibers Could Carry Drugs and Light Up Cells at Once

Imagine a material built from the same mineral that makes up your bones and teeth, but engineered to glow a distinctive red under laser light and to cling to therapeutic plant molecules on its surface. A team of researchers in Mexico has now reported a detailed recipe for making exactly that: europium-doped hydroxyapatite nanofibers, synthesized in minutes inside a microwave reactor, whose structure, morphology, and optical behavior can be tuned with surprising precision by adjusting temperature, acidity, and dopant concentration. In a study published in Results in Chemistry, Carolina Lazaro-Vidal and colleagues describe how these luminescent calcium phosphate nanostructures also show preliminary promise as carriers for quercetin, an antioxidant flavonoid of growing pharmaceutical interest.

Hydroxyapatite, with the chemical formula Ca10(PO4)6(OH)2 and a calcium-to-phosphorus ratio of 1.67, is the inorganic scaffold of human bone and dental enamel. Because it is biocompatible, non-toxic, and non-inflammatory, and because its porous structure offers a large surface area, materials scientists have long viewed it as an ideal candidate for bone regeneration and for controlled drug delivery. An efficient delivery system, however, needs more than biocompatibility. It must load therapeutic molecules, transport them to target tissues, and release them predictably, ideally in response to physiological cues such as the acidic pH found in tumor environments, where hydroxyapatite dissolves more readily and can dump its cargo on cue.

The Mexican team added a second function to this already versatile material: light. Europium ions, Eu3+, belong to the rare-earth family and emit sharp, photostable red luminescence when excited, a property that makes them valuable for cellular imaging and diagnostic applications. The catch is that europium can be toxic at high concentrations, and too much of it in a crystal lattice causes luminescence quenching, an energy-draining conversation between neighboring dopant ions that snuffs out the very glow the dopant was added to provide. The researchers therefore kept europium levels low, testing 2, 3, and 4 molar percent relative to calcium, and relied on the nanofiber geometry to place the emitting ions near the surface, where their light is easier to harvest.

The synthesis itself is a study in efficiency. Using a microwave-assisted hydrothermal method, the team combined calcium nitrate and glutamic acid, an amino acid that steers crystal growth, with potassium phosphate and potassium hydroxide solutions. Microwave irradiation heats the reaction mixture rapidly and uniformly, and sealed vials were reacted at 170 degrees Celsius for just 45 minutes at pressures of 10 to 11 bar. For the doped samples, a third solution of europium nitrate was added at carefully calculated stoichiometries. Each synthesis yielded roughly 0.11 to 0.17 grams of product, and the researchers ran three distinct methodologies, varying precursor temperatures, pH, and the way europium entered the recipe, to map how each parameter shaped the final material.

X-ray diffraction revealed that every sample crystallized predominantly in the hexagonal hydroxyapatite phase, with sharp Bragg reflections indicating high crystallinity. More intriguing was a systematic anomaly: the standard reference pattern predicts that the (300) reflection should reach only about 62 percent of the intensity of the dominant (211) peak, yet in these samples the (300) reflection frequently matched or exceeded it. This inversion is the fingerprint of preferential crystalline orientation, a consequence of the glutamic acid and microwave method working together. Because the (100) and (300) planes that terminate the nanofibers are rich in calcium ions, they are prime real estate for europium substitution, positioning the dopant where its emission can escape the crystal most easily.

Crystallite size and lattice strain told a subtler story. Using both the Scherrer equation and the Williamson-Hall method, which accounts for strain broadening that Scherrer ignores, the team found that Methodology 1 produced the largest, most pristine crystallites, around 280 angstroms, with microstrain below 0.02 percent in doped samples. Methodology 2, with its pH manipulation, yielded smaller crystallites as low as 152 angstroms and the highest microstrain measured, 0.186 percent, signaling dense defects and lattice distortion. Methodology 3 struck a balance, and its samples grew into strikingly well-formed hexagonal nanofibers hundreds of nanometers long, with sides of about 205 nanometers and long diagonals of 390 nanometers. Electron microscopy confirmed the trend: uniform smooth fibers in Methodology 1, fragmented disordered particles in Methodology 2, and large, aligned, well-faceted fibers in Methodology 3.

Dopant concentration sculpted morphology in unexpected ways. At 2 percent europium, the fibrous habit survived intact, suggesting the ions slipped neatly into calcium sites. At 3 percent, fibers thickened and agglomerated, with irregular particles and partially fused regions appearing as the mismatch between the larger Eu3+ radius and Ca2+ disrupted the balance between nucleation and growth. At 4 percent, however, the material rebounded, producing longer, thicker, more aligned fibers, apparently because excess europium promoted directional growth along the crystallographic c-axis, though localized agglomerates hinted at europium-rich amorphous pockets. Photoluminescence spectroscopy added another layer: the splitting pattern of the 5D0 to 7F1 transition showed more lines than theory predicts for a single site, indicating that europium occupies both calcium site types, and possibly interstitial positions, simultaneously.

With 3 percent europium selected as the optimal compromise, preserving the apatite phase, fibrous morphology, and detectable red emission, the team turned to quercetin. Three formulations were prepared by stirring 0.100 grams of the doped nanofibers with 0.005, 0.010, or 0.020 grams of quercetin in ethanol for 24 hours at 30 degrees Celsius, corresponding to weight ratios of 10:0.5, 10:1, and 10:2. After centrifugation, washing, and drying, electron microscopy showed the fibrous network largely preserved but decorated with small granular deposits absent from unloaded samples, evidence that quercetin adsorbs onto the fiber surfaces, likely through hydrogen bonding and electrostatic interactions with the calcium phosphate, rather than infiltrating pores. Energy-dispersive spectroscopy detected carbon consistent with the organic molecule, though its uneven distribution across analyzed regions suggested the adsorption is patchy rather than uniform.

Infrared spectroscopy was less conclusive. Because hydroxyapatite phosphate bands overlap with quercetin’s organic signals and the loaded amounts were small, the spectra showed only subtle changes: a phenolic OH signal near 1200 wavenumbers, aromatic CH stretches around 2959 to 2855, and weak carbon-carbon double-bond bands. The absence of new bands suggests the interaction is physical, mediated by hydrogen bonds, with no chemical reaction. Crucially, loading quercetin did not shift the positions of the characteristic europium emission transitions, meaning the optical tag survives the drug-loading process. That combination, a bone-like scaffold that glows red, carries a bioactive molecule on its surface, and keeps its luminescence intact, is precisely what a multifunctional theragnostic platform would need.

The authors are careful about limits. The physicochemical data represent single measurements without statistical replicates, the EDS technique is localized and semiquantitative, and nothing in the study establishes biological safety; cytocompatibility, ion-release, and cellular uptake experiments remain to be done before any clinical ambition can be entertained. Quantitative adsorption capacity, release kinetics, and reproducibility also await measurement. But as a proof of concept, the work demonstrates that a microwave-assisted, amino-acid-guided synthesis can deliver a luminescent calcium phosphate nanocarrier in under an hour, with morphology and dopant behavior controlled by recipe rather than chance. If the follow-up biology holds, the same mineral that builds skeletons may one day light the way for medicines traveling through the body.

Subject of Research: Europium-doped hydroxyapatite nanostructures for luminescent imaging and quercetin drug delivery

Article Title: Physicochemical and photoluminescent properties of Eu 3+ -doped hydroxyapatite nanostructures and preliminary quercetin adsorption study

Article References: Lazaro-Vidal, C., Méndez-Lozano, N., Alanis-Gómez, J. R., Hernández-Rosas, F., Rivera-Muñoz, E., & Velazquez-Castillo, R. (2026). Physicochemical and photoluminescent properties of Eu3+-doped hydroxyapatite nanostructures and preliminary quercetin adsorption study. Results in Chemistry, 31, Article 103956. https://doi.org/10.1016/j.rechem.2026.103956

Image Credits: AI Generated

DOI: 10.1016/j.rechem.2026.103956

Keywords: hydroxyapatite, europium doping, nanofibers, photoluminescence, quercetin, drug delivery, microwave-assisted hydrothermal synthesis, X-ray diffraction, biomedical imaging, calcium phosphate, nanomaterials, theragnostics